Literature DB >> 4993411

Inhibition of serine proteases by arylboronic acids.

M Philipp, M L Bender.   

Abstract

Arylboronic acids were found to be strong competitive inhibitors of subtilisin and chymotrypsin. The binding constants are strongly pH dependent and give a Hammett-type plot with a slope of -0.885. The pH dependence, the Hammett plot, and nmr model-system studies indicate that inhibition is due to electron-pair donation by the active site histidine to the bound inhibitor.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4993411      PMCID: PMC388964          DOI: 10.1073/pnas.68.2.478

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  6 in total

1.  n-Alkylboronic acids as bifunctional reversible inhibitors of alpha-chymotrypsin.

Authors:  V K. Antonov; T V. Ivanina; I V. Berezin; K Martinek
Journal:  FEBS Lett       Date:  1970-03-16       Impact factor: 4.124

2.  A spectrophotometric determination of trypsin and chymotrypsin.

Authors:  G W SCHWERT; Y TAKENAKA
Journal:  Biochim Biophys Acta       Date:  1955-04

3.  The reactivity of thiol-subtilisin, an enzyme containing a synthetic functional group.

Authors:  L Polgar; M L Bender
Journal:  Biochemistry       Date:  1967-02       Impact factor: 3.162

4.  Esteratic reactions catalyzed by subtilisins.

Authors:  A N Glazer
Journal:  J Biol Chem       Date:  1967-02-10       Impact factor: 5.157

5.  Binding of competitive inhibitors to delta-chymotrypsin in the alkaline pH region. Competitive inhibition kinetics and proton-uptake measurements.

Authors:  P Valenzuela; M L Bender
Journal:  Biochemistry       Date:  1970-06-09       Impact factor: 3.162

6.  Spectral studies of the interaction of alpha-chymotrypsin and trypsin with proflavine.

Authors:  A N Glazer
Journal:  Proc Natl Acad Sci U S A       Date:  1965-07       Impact factor: 11.205

  6 in total
  17 in total

1.  The use of alpha-aminoboronic acid derivatives to stabilize peptide drugs during their intranasal absorption.

Authors:  M A Hussain; A B Shenvi; S M Rowe; E Shefter
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

2.  Irreversible inhibition of a monoclonal antibody by a nitrophenyl ester.

Authors:  G Rao; M Philipp
Journal:  J Protein Chem       Date:  1991-02

3.  Serine-borate complex as a transition-state inhibitor of gamma-glutamyl transpeptidase.

Authors:  S S Tate; A Meister
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

4.  Inhibitors of angiotensin-converting enzyme containing a tetrahedral arsenic atom.

Authors:  R E Galardy; Z P Kortylewicz
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

Review 5.  Molecular recognition with boronic acids-applications in chemical biology.

Authors:  Gillian F Whyte; Ramon Vilar; Rudiger Woscholski
Journal:  J Chem Biol       Date:  2013-06-01

6.  Proteases of Treponema denticola outer sheath and extracellular vesicles.

Authors:  G Rosen; R Naor; E Rahamim; R Yishai; M N Sela
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  Beta-lactamase inhibitors. The inhibition of serine beta-lactamases by specific boronic acids.

Authors:  I E Crompton; B K Cuthbert; G Lowe; S G Waley
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

8.  Inactivation of the RTEM-1 cysteine beta-lactamase by iodoacetate. The nature of active-site functional groups and comparisons with the native enzyme.

Authors:  A K Knap; R F Pratt
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

9.  Proteus mirabilis urease. Partial purification and inhibition by boric acid and boronic acids.

Authors:  J M Breitenbach; R P Hausinger
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

10.  1H, 13C and 15N NMR backbone assignments and secondary structure of the 269-residue protease subtilisin 309 from Bacillus lentus.

Authors:  M L Remerowski; T Domke; A Groenewegen; H A Pepermans; C W Hilbers; F J van de Ven
Journal:  J Biomol NMR       Date:  1994-03       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.